about
Sigma receptors: potential targets for a new class of antidepressant drugTo use or not to use: an update on licit and illicit ketamine usePreclinical pharmacology and pharmacokinetics of CERC-301, a GluN2B-selective N-methyl-D-aspartate receptor antagonistGlutamatergic targets for new alcohol medicationsNovel NMDA receptor modulators: an updateThe neurobiology of anhedonia and other reward-related deficitsNMDA receptor modulators: an updated patent review (2013-2014)Neurobiology of chronic mild stress: parallels to major depressionCharacterization of an mGluR2/3 negative allosteric modulator in rodent models of depressionGlutamate receptor ion channels: structure, regulation, and functionLong-lasting antidepressant action of ketamine, but not glycogen synthase kinase-3 inhibitor SB216763, in the chronic mild stress model of miceThe qEEG Signature of Selective NMDA NR2B Negative Allosteric Modulators; A Potential Translational Biomarker for Drug DevelopmentChronic Treatment with the IDO1 Inhibitor 1-Methyl-D-Tryptophan Minimizes the Behavioural and Biochemical Abnormalities Induced by Unpredictable Chronic Mild Stress in Mice - Comparison with FluoxetineRapid antidepressants stimulate the decoupling of GABA(B) receptors from GIRK/Kir3 channels through increased protein stability of 14-3-3ηStress-induced changes of hippocampal NMDA receptors: modulation by duloxetine treatmentThe three-hit concept of vulnerability and resilience: toward understanding adaptation to early-life adversity outcome.GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects.Differential role of NR2A and NR2B subunits in N-methyl-D-aspartate receptor antagonist-induced aberrant cortical gamma oscillations.Forebrain glutamatergic neurons mediate leptin action on depression-like behaviors and synaptic depressionThe role of GluN2A and GluN2B subunits on the effects of NMDA receptor antagonists in modeling schizophrenia and treating refractory depressionFMRP regulates an ethanol-dependent shift in GABABR function and expression with rapid antidepressant properties.Synapse regression in depression: the role of 5-HT receptors in modulating NMDA receptor function and synaptic plasticity.Therapeutic infusions of ketamine: do the psychoactive effects matter?Psychiatric disorders: diagnosis to therapyThe effects of subanesthetic ketamine infusions on motivation to quit and cue-induced craving in cocaine-dependent research volunteers.Social isolation-induced aggression potentiates anxiety and depressive-like behavior in male mice subjected to unpredictable chronic mild stressModifying 5-HT1A Receptor Gene Expression as a New Target for Antidepressant Therapy.A randomized add-on trial of high-dose D-cycloserine for treatment-resistant depression.Modulation of synaptic plasticity by stress hormone associates with plastic alteration of synaptic NMDA receptor in the adult hippocampus.Innovative approaches to treatment - refractory depression: The ketamine story.Lack of efficacy of NMDA receptor-NR2B selective antagonists in the R6/2 model of Huntington disease.Antidepressant Effects of Ketamine on Depression-like Behavior in Juvenile Mice after Neonatal Dexamethasone Exposure.The role of proteomics in depression researchOn the mechanism of the antidepressant-like action of group II mGlu receptor antagonist, MGS0039.Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disordersA randomized trial of a low-trapping nonselective N-methyl-D-aspartate channel blocker in major depression.Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders.A new strategy for antidepressant prescription.AMPAkines have novel analgesic properties in rat models of persistent neuropathic and inflammatory pain.Antidepressants that inhibit both serotonin and norepinephrine reuptake impair long-term potentiation in hippocampus.
P2860
Q24567770-FCD4B7AE-79E1-4C93-925D-139395890E16Q24634006-59E16F88-9FE9-4E95-9CF6-7D97FB6B78C4Q26750021-649AAD3C-848D-445D-9F35-E73E89C1C490Q26824012-DBEA366E-9FD4-45A0-9804-29AC08115A6FQ26849614-D89D479B-C201-4DFC-A5F2-F6A813E725CCQ26853518-3AF46107-6AEE-4B9D-B8AB-A5821B02DA55Q26997407-D8EB8062-0B0B-4562-9C38-A1B0431A5C57Q27026698-ABF4CA04-9FAB-4A69-A4D8-22D1B0BB00B8Q28253233-E94D476D-E497-4EAB-9E2E-521330FB7851Q28290774-464F6B6A-CD5E-4361-9EBF-4335324099F5Q28485938-5353F505-0BC9-488E-9BBC-92814A9A0412Q28551131-3BC14E33-BA2C-49CC-AAC4-C51EE10DD1B8Q28553299-4504978F-2BDC-4B71-9109-871F4BBA6DA4Q28652455-0B2EE249-F52C-47FB-B375-AF53170B33E9Q28729135-6E5DB59D-34DC-40FE-9C01-FD15867C1192Q30432090-8052E814-2797-476D-BBD8-A2F49CA366E0Q30440925-DED53905-A6E6-4469-95CD-A2956D16FDB0Q30453949-2CF38FF4-D6F3-4208-8DFE-8F00A1DEB90CQ30508512-9341524E-C1C5-473A-BA7A-C3116AED892BQ30595767-55E6DCCD-1023-4CE9-AABC-5E01BD17DAAEQ30819120-45B8D5A8-F5ED-4E33-B7E9-3811AAE0CF03Q33543949-E795AEF9-8DD6-4355-BAE0-FE505D490386Q33880853-E592B260-B5D3-4603-9F08-2C8DA8B5886AQ33922884-6EFD291F-BEA5-40B6-B168-3EF45E6276CAQ33926787-10BC2CB5-B3D5-4412-99D0-28AA4020B297Q33940576-82F31B78-F42F-4760-841B-34D84C47FB3AQ34008064-3DA4B498-4E73-4047-A0A3-16DE16BEA3E4Q34034492-5DC494CB-F38B-4961-AE01-F6320499FC6CQ34070607-E9799B8C-96DD-41FE-B17D-BC31711DF28EQ34082689-5B779CEC-4727-4392-A980-D6A2EF501737Q34126315-6411BE97-8924-4FCB-900B-4620867B7492Q34129846-E7AD87D0-F629-46CD-B35C-B8EA3333033FQ34130553-8AD542DB-30CB-43F9-9409-3F5601E7857AQ34130874-BF849945-4B73-4987-89BA-678A5376A6A3Q34204211-AE4AC08F-8A22-4CE4-833E-4E58CBE0FDD0Q34315128-97F9DDA1-C32D-4AB9-80D9-F94DA194E5ECQ34330678-87366E77-2F7D-4B31-841F-38D405FB10CAQ34371007-1F75C3B9-59DA-476F-A641-359B17D64502Q34390309-B420A32E-E0AF-4A90-B7C6-A7258164FCA6Q34429428-295AFCC3-2C67-4DB0-9483-D71AA6203C22
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Glutamate-based antidepressants: 20 years on.
@en
Glutamate-based antidepressants: 20 years on.
@nl
type
label
Glutamate-based antidepressants: 20 years on.
@en
Glutamate-based antidepressants: 20 years on.
@nl
prefLabel
Glutamate-based antidepressants: 20 years on.
@en
Glutamate-based antidepressants: 20 years on.
@nl
P1476
Glutamate-based antidepressants: 20 years on.
@en
P2093
Phil Skolnick
P304
P356
10.1016/J.TIPS.2009.09.002
P577
2009-11-01T00:00:00Z